During the past decade, Clearwater Cardiovascular Consultants conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 14 clinical trials were completed, i.e. on average, 48.3% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 9 clinical trials were completed. i.e. 69.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clearwater Cardiovascular Consultants" #1 sponsor was "Boston Scientific Corporation" with 4 trials, followed by "Medtronic" with 3 trials sponsored, "Abbott Medical Devices" with 2 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Cardiovascular Systems Inc" with 2 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clearwater Cardiovascular Consultants" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "American College of Cardiology" with 1 trials as a collaborator, "Boston VA Research Institute, Inc." with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator and "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Clearwater Cardiovascular Consultants" are "Coronary Artery Disease" (7 trials), "Heart Failure" (7 trials), "Acute Coronary Syndrome" (2 trials), "Atherosclerosis" (2 trials) and "Atherosclerotic Cardiovascular Disease" (2 trials). Many other conditions were trialed in "Clearwater Cardiovascular Consultants" in a lesser frequency.

Most popular intervention types in "Clearwater Cardiovascular Consultants" are "Device" (19 trials), "Drug" (15 trials), "Other" (6 trials), "Biological" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Empagliflozin" (2 trials), "2nd generation DES (XIENCE family, Promus family, Resolute/Onyx family/Endeavor, and Orsiro stent)" (1 trials), "AcQMap System" (1 trials) and "Acetylsalicylic acid" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clearwater Cardiovascular Consultants" are 42 trials for "All" genders.

Currently, there are NaN active trials in "Clearwater Cardiovascular Consultants". undefined are not yet recruiting, 10 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 19 completed trials in Clearwater Cardiovascular Consultants, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Clearwater Cardiovascular Consultants, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 10 trials that are defined as “Not Applicable".